These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8112842)

  • 1. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
    Mukherjee S; Lee S; Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1994 Mar; 62(3):1079-88. PubMed ID: 8112842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.
    Mukherjee J; Zuckier LS; Scharff MD; Casadevall A
    Antimicrob Agents Chemother; 1994 Mar; 38(3):580-7. PubMed ID: 8203858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.
    Mukherjee J; Feldmesser M; Scharff MD; Casadevall A
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1398-405. PubMed ID: 7492075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
    Mukherjee J; Kozel TR; Casadevall A
    J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
    Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1995 Sep; 63(9):3353-9. PubMed ID: 7642262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
    Cleare W; Cherniak R; Casadevall A
    Infect Immun; 1999 Jun; 67(6):3096-107. PubMed ID: 10338526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
    Casadevall A; Mukherjee J; Devi SJ; Schneerson R; Robbins JB; Scharff MD
    J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.
    Goldman DL; Lee SC; Casadevall A
    Infect Immun; 1995 Sep; 63(9):3448-53. PubMed ID: 7642276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.
    Nussbaum G; Anandasabapathy S; Mukherjee J; Fan M; Casadevall A; Scharff MD
    Infect Immun; 1999 Sep; 67(9):4469-76. PubMed ID: 10456888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans.
    Feldmesser M; Kress Y; Casadevall A
    J Infect Dis; 1998 Jun; 177(6):1639-46. PubMed ID: 9607844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.
    Feldmesser M; Casadevall A
    J Immunol; 1997 Jan; 158(2):790-9. PubMed ID: 8992996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.
    Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z
    Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
    Maitta RW; Datta K; Chang Q; Luo RX; Witover B; Subramaniam K; Pirofski LA
    Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan.
    Casadevall A; DeShaw M; Fan M; Dromer F; Kozel TR; Pirofski LA
    Infect Immun; 1994 Sep; 62(9):3864-72. PubMed ID: 8063403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.
    Mukherjee J; Pirofski LA; Scharff MD; Casadevall A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3636-40. PubMed ID: 8475112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus neoformans infection can elicit protective antibodies in mice.
    Mukherjee J; Scharff MD; Casadevall A
    Can J Microbiol; 1994 Oct; 40(10):888-92. PubMed ID: 8000967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
    Beenhouwer DO; May RJ; Valadon P; Scharff MD
    J Immunol; 2002 Dec; 169(12):6992-9. PubMed ID: 12471134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
    Rodríguez Sánchez H; Pupo Antúnez M; Ilnait MT; Otero A; Martínez Machín G
    Rev Cubana Med Trop; 2005; 57(2):162-4. PubMed ID: 17966590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.
    Probert M; Zhou X; Goodall M; Johnston SA; Bielska E; Ballou ER; May RC
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide.
    Lendvai N; Casadevall A; Liang Z; Goldman DL; Mukherjee J; Zuckier L
    J Infect Dis; 1998 Jun; 177(6):1647-59. PubMed ID: 9607845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.